216 related articles for article (PubMed ID: 12068373)
21. Alternative 5' exons of the CFTR gene show developmental regulation.
Mouchel N; Broackes-Carter F; Harris A
Hum Mol Genet; 2003 Apr; 12(7):759-69. PubMed ID: 12651871
[TBL] [Abstract][Full Text] [Related]
22. Does distance matter? Variations in alternative 3' splicing regulation.
Akerman M; Mandel-Gutfreund Y
Nucleic Acids Res; 2007; 35(16):5487-98. PubMed ID: 17704130
[TBL] [Abstract][Full Text] [Related]
23. Multiple splicing defects in an intronic false exon.
Sun H; Chasin LA
Mol Cell Biol; 2000 Sep; 20(17):6414-25. PubMed ID: 10938119
[TBL] [Abstract][Full Text] [Related]
24. Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of alpha-actinin mutally exclusive exons.
Southby J; Gooding C; Smith CW
Mol Cell Biol; 1999 Apr; 19(4):2699-711. PubMed ID: 10082536
[TBL] [Abstract][Full Text] [Related]
25. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.
Chu CS; Trapnell BC; Curristin S; Cutting GR; Crystal RG
Nat Genet; 1993 Feb; 3(2):151-6. PubMed ID: 7684646
[TBL] [Abstract][Full Text] [Related]
26. A donor splice mutation (405 + 1 G-->A) in cystic fibrosis associated with exon skipping in epithelial CFTR mRNA.
Dörk T; Will K; Demmer A; Tümmler B
Hum Mol Genet; 1993 Nov; 2(11):1965-6. PubMed ID: 7506605
[No Abstract] [Full Text] [Related]
27. A novel mutation (c.121‑13T>A) in the polypyrimidine tract of the splice acceptor site of intron 2 causes exon 3 skipping in mitochondrial acetoacetyl-CoA thiolase gene.
Aoyama Y; Sasai H; Abdelkreem E; Otsuka H; Nakama M; Kumar S; Aroor S; Shukla A; Fukao T
Mol Med Rep; 2017 Jun; 15(6):3879-3884. PubMed ID: 28393214
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
Buratti E; Dörk T; Zuccato E; Pagani F; Romano M; Baralle FE
EMBO J; 2001 Apr; 20(7):1774-84. PubMed ID: 11285240
[TBL] [Abstract][Full Text] [Related]
30. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing.
Hefferon TW; Groman JD; Yurk CE; Cutting GR
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3504-9. PubMed ID: 14993601
[TBL] [Abstract][Full Text] [Related]
31. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
Ashiya M; Grabowski PJ
RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
[TBL] [Abstract][Full Text] [Related]
32. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
33. A novel donor splice site characterized by CFTR mRNA analysis induces a new pseudo-exon in CF patients.
Costantino L; Claut L; Paracchini V; Coviello DA; Colombo C; Porcaro L; Capasso P; Zanardelli M; Pizzamiglio G; Degiorgio D; Seia M
J Cyst Fibros; 2010 Dec; 9(6):411-8. PubMed ID: 20875776
[TBL] [Abstract][Full Text] [Related]
34. Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361+1G>A mutation identified by NGS.
Niba ETE; Nishida A; Tran VK; Vu DC; Matsumoto M; Awano H; Lee T; Takeshima Y; Nishio H; Matsuo M
J Hum Genet; 2017 Apr; 62(5):531-537. PubMed ID: 28100912
[TBL] [Abstract][Full Text] [Related]
35. Alternative splicing of the human estrogen receptor alpha primary transcript: mechanisms of exon skipping.
Ferro P; Forlani A; Muselli M; Pfeffer U
Int J Mol Med; 2003 Sep; 12(3):355-63. PubMed ID: 12883652
[TBL] [Abstract][Full Text] [Related]
36. Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells.
Carothers AM; Urlaub G; Grunberger D; Chasin LA
Mol Cell Biol; 1993 Aug; 13(8):5085-98. PubMed ID: 8336736
[TBL] [Abstract][Full Text] [Related]
37. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
38. A G-to-T transversion at the splice acceptor site of dystrophin exon 14 shows multiple splicing outcomes that are not exemplified by transition mutations.
Ota M; Takeshima Y; Nishida A; Awano H; Lee T; Yagi M; Matsuo M
Genet Test Mol Biomarkers; 2012 Jan; 16(1):3-8. PubMed ID: 21854195
[TBL] [Abstract][Full Text] [Related]
39. Role of an inhibitory pyrimidine element and polypyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon.
Gooding C; Roberts GC; Smith CW
RNA; 1998 Jan; 4(1):85-100. PubMed ID: 9436911
[TBL] [Abstract][Full Text] [Related]
40. Single-nucleotide substitution T to A in the polypyrimidine stretch at the splice acceptor site of intron 9 causes exon 10 skipping in the
Sasai H; Aoyama Y; Otsuka H; Abdelkreem E; Nakama M; Hori T; Ohnishi H; Turner L; Fukao T
Mol Genet Genomic Med; 2017 Mar; 5(2):177-184. PubMed ID: 28361105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
